Literature DB >> 14512917

Horizontal advancement flap for symmetric reconstruction of small to medium-sized cutaneous defects of the lateral nasal supratip.

Leonard H Goldberg1, Murad Alam.   

Abstract

BACKGROUND: Aesthetic repair of small cutaneous defects of the nose is a common challenge for the dermatologic surgeon because nonmelanoma cancers occur frequently in this location.
OBJECTIVE: Our aim was to devise a simple flap for repair of small to medium-sized defects of the lateral nasal supratip.
METHODS: The mechanics of the proposed horizontal advancement ("east-west") flap are described. Patient selection, flap design, and flap mechanics are discussed. The benefits and limitations of this repair are compared with those of alternative closures.
RESULTS: The horizontal-advancement flap is an easily visualized, constructed, and executed flap that permits repair of small to moderately sized lateral nasal supratip defects without inducing asymmetry of the nasal architecture. The flap is well camouflaged in skin lines, the ala and nares are not distorted, and the large, untwisted pedicle contributes to flap viability. Large defects and defects far lateral to the midline may not be amenable to this repair.
CONCLUSIONS: In selected patients with small to medium-sized lateral nasal supratip defects, the horizontal advancement flap is a simple, reliable, and aesthetically pleasing reconstruction option.

Entities:  

Mesh:

Year:  2003        PMID: 14512917     DOI: 10.1067/s0190-9622(03)01833-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Levator anguli oris muscle based flaps for nasal reconstruction following resection of nasal skin tumours.

Authors:  Adel Denewer; Omar Farouk; Tamer Fady; Fayez Shahatto
Journal:  World J Surg Oncol       Date:  2011-02-18       Impact factor: 2.754

2.  Versatility of advancement flaps for nasal reconstruction following Mohs` micrographic surgery.

Authors:  Felipe Bochnia Cerci
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.